Course

This course will ensure that clinicians will have the working knowledge of evidence that supports rapid start of antiretroviral treatment for people with HIV infection, data supporting HIV treatment as prevention and the “Undetectable = Untransmittable” statement as a Public Health campaign, safe and efficacious rapid ART regimens based on known patient characteristics, as well as regimens to avoid, and patient-level and institutional barriers and best practices for implementation.

Please note: 

Since we created this presentation, New York State updated its Rapid ART guidelines. “Clinicians should offer rapid initiation of ART—preferably on the same day or within 72 hours—to all individuals who are candidates for rapid ART initiation and who have a confirmed HIV diagnosis or a reactive HIV screening result pending results of a confirmatory HIV test or suspected acute HIV infection, i.e., HIV antibody negative and HIV RNA positive.” This presentation includes the outdated recommendation of 96 hours.